Federal law targets deceptive abortion clinic ads targeting low-income women

What it does

This bill makes it illegal for any organization—including crisis pregnancy centers (CPCs)—to advertise deceptively about reproductive health services they offer or don't offer. Specifically, it prohibits false claims that an organization provides abortion or contraception services (or referrals), or that it employs licensed medical personnel. The Federal Trade Commission enforces the rule through civil penalties up to $100,000 per violation or 50% of the violator's annual revenue, whichever is greater. The bill targets CPCs, which the findings describe as anti-abortion organizations that use deceptive tactics to discourage abortion access, particularly in low-income and communities of color.

Why we flagged it

The bill's operative mechanism is a consumer-protection rule prohibiting deceptive advertising in the reproductive health sector. While framed around abortion access, the actual legal tool is FTC enforcement of truth-in-advertising standards, making it a consumer-protection measure with abortion-access implications.

What the text implies

• The bill grants the FTC enforcement authority over nonprofit organizations (CPCs) that would normally fall outside FTC jurisdiction, expanding the Commission's reach into the nonprofit sector.
• Civil penalties of up to 50% of annual revenue are unusually severe and may have a chilling effect on all organizations in the reproductive health space, not just those engaged in deception.
• The definition of 'deceptive advertising' is tied to claims about services offered or credentials held; the bill does not directly regulate the content of medical claims about abortion risks/benefits, leaving that boundary somewhat unclear.
• Enforcement depends on FTC rulemaking and litigation; the bill does not create a private right of action, so individual consumers cannot sue directly—only the FTC can enforce.
• The findings extensively document disparate impact on low-income women and women of color, but the remedy (advertising regulation) is indirect and may not address underlying access barriers like travel distance or cost.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Ordinary citizens gain a right to truthful advertising about reproductive health services and are protected from deceptive practices that delay or prevent access to time-sensitive care. The bill addresses a documented pattern of deception targeting low-income people and communities of color, removing a barrier to informed decision-making about abortion access.

Named in the bill

Federal Trade Commission (FTC), Crisis Pregnancy Centers (CPCs), Department of Justice / Attorney General, Abortion clinics / reproductive health providers

Where it stands

12 cosponsors: 11 Democrats, 1 Independents.

• Feb 13, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• Feb 13, 2025 — Referred to Senate Committee on Commerce, Science, and Transportation · Congress.gov: “Read twice and referred to the Committee on Commerce, Science, and Transportation”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

3 lobbying clients named this bill on 5 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $1,759,355 in lobbying spend. A filing names 48 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 61% of bills with at least one filing.

Elizabeth Warren, the sponsor, reported $19,000 in PAC receipts in the 2026 cycle.

• American Academy of Family Physicians — $1,715,904 on 2 filings
• Power to Decide — $33,451 on 2 filings
• National Council of Jewish Women — $10,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.